Differential Diagnosis and Management of Palpitations in Elderly Patients
Most Critical Life-Threatening Causes to Rule Out First
- The American Heart Association recommends prioritizing evaluation for ventricular arrhythmias and structural heart disease in elderly patients presenting with palpitations, as 70-80% of persons over age 60 have ventricular arrhythmias, which often presage major coronary events and sudden cardiac death 1
- Ventricular tachycardia (VT) and ventricular fibrillation (VF) are the primary concerns, as complex ventricular arrhythmias predict new major coronary events and sudden cardiac death in elderly patients with coronary heart disease and structural heart disease 1, 2
- The incidence of sudden cardiac death increases with advancing age, with coronary heart disease (CHD) accounting for >80% of sudden cardiac deaths in elderly patients 1, 2, 3
Essential Initial Diagnostic Workup
- The American College of Cardiology recommends a thorough history, including associated symptoms, timing patterns, precipitating factors, and symptom characteristics, to identify potentially serious arrhythmias requiring urgent evaluation 6
- Orthostatic vital signs are particularly important in older patients, and a 12-lead ECG is essential to identify baseline cardiac rhythm, conduction abnormalities, pre-excitation, or evidence of structural heart disease 4, 6
Management Approach Framework
- The European Society of Cardiology recommends that elderly patients with ventricular arrhythmias should generally be treated in the same manner as younger individuals, with a Class I recommendation and Level of Evidence A 1, 2, 7
- The American Heart Association suggests that dosing and titration of antiarrhythmic drugs must be adjusted for altered pharmacokinetics in elderly patients, with a recommendation to start at lower than usual doses and titrate at longer intervals with smaller dose increments 1, 3, 8
- Beta blockers reduce all-cause mortality and sudden cardiac death post-MI in all age groups, including elderly, with the greatest benefit in ages 60-69 years 3
Device Therapy
- The American College of Cardiology recommends ICD therapy for both primary and secondary prevention, with equivalent benefits in older and younger patients 9
- However, a Class III recommendation suggests that elderly patients with projected life expectancy <1 year due to major comorbidities should not receive ICD therapy 1, 2, 7, 9